应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
09941 先通医药-B
待上市 11-16 16:00:00
0.000
+0.000
--
最高
0.000
最低
0.000
成交量
0.00
今开
0.000
昨收
0.000
日振幅
0.00%
总市值
0.00
流通市值
0.00
总股本
5,905万
成交额
0.00
换手率
0.00%
流通股本
5,905万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
先通医药开启招股:拟募资4.5亿港元 11月24日上市 上半年亏5亿
雷递网 · 10:49
先通医药开启招股:拟募资4.5亿港元 11月24日上市 上半年亏5亿
新股招股 | 先通医药-B今起招股,一手入场费3434.29港元
老虎资讯综合 · 09:25
新股招股 | 先通医药-B今起招股,一手入场费3434.29港元
“核药第一股”先通医药今起招股,预计11月24日挂牌上市,茅台、国资为股东
独角兽早知道 · 08:11
“核药第一股”先通医药今起招股,预计11月24日挂牌上市,茅台、国资为股东
先通医药-B(09941)11月16日至11月19日招股 拟全球发售656.1万股H股
智通财经 · 06:55
先通医药-B(09941)11月16日至11月19日招股 拟全球发售656.1万股H股
北京先通国际医药科技全球发售启动,最高募资约3.291亿港元
公告速递 · 06:47
北京先通国际医药科技全球发售启动,最高募资约3.291亿港元
北京先通顺际医药科技启动全球发售:拟发行6,561,000股H股并设15%超额配股权
公告速递 · 06:46
北京先通顺际医药科技启动全球发售:拟发行6,561,000股H股并设15%超额配股权
北京先通国际医药科技股份有限公司启动全球发售,计划11月24日登陆港交所
公告速递 · 06:35
北京先通国际医药科技股份有限公司启动全球发售,计划11月24日登陆港交所
先通医药通过上市聆讯:上半年营收6125万 净亏5亿
雷递网 · 11-01
先通医药通过上市聆讯:上半年营收6125万 净亏5亿
新股消息 | 先通医药通过港交所聆讯 为中国首家获得创新放射性药物上市批准的企业
智通财经 · 10-29
新股消息 | 先通医药通过港交所聆讯 为中国首家获得创新放射性药物上市批准的企业
暂无数据
公司概况
公司名称:
先通医药-B
所属市场:
SEHK
上市日期:
--
主营业务:
先通医药专注于创新放射性药物的研发及商业化,布局神经、心血管和肿瘤疾病领域,开发用于精准诊断和靶向治疗的放射性药物。公司总部位于北京,在上海设有研发中心,在江苏、广东和四川建设放射性药物生产基地,并在美国设有分支机构。
发行价格:
--
{"stockData":{"symbol":"09941","market":"HK","secType":"STK","nameCN":"先通医药-B","latestPrice":0,"timestamp":1794816000000,"preClose":0,"halted":7,"volume":0,"delay":0,"floatShares":59048600,"shares":59048600,"eps":0,"marketStatus":"待上市","change":0,"latestTime":"11-16 16:00:00","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1795483800000},"marketStatusCode":8,"adr":0,"listingDate":1795449600000,"exchange":"SEHK","adjPreClose":0,"openAndCloseTimeList":[[1794792600000,1794801600000],[1794805200000,1794816000000]],"volumeRatio":0,"ipoDetail":{"name":"先通医药-B","exchange":"SEHK","listingDate":"2026-11-24","sharesOutstanding":65609614,"sharesFloat":65609614,"offerAmount":6561000,"priceRange":"52.00 - 68.00","market":"HK","openProspectusDate":"2026-11-16","openProspectusUrl":"https://ossnoticepdf.iqdii.com/stockdata/notice/09941/2026/2026111600012_c.pdf","purchaseBeginDate":"2026-11-16","purchaseEndDate":"2026-11-19","winningDate":"2026-11-23","currency":"HKD","minPurchaseQuantity":50,"peRate":-5.83,"use":"1、88.0%(约289.5百万港元)将用于核心产品的研发及注册申报;\n2、4.9%(约16.1百万港元)将用于其他候选产品的研发;\n3、1.1%(约3.5百万港元)将用于加强销售及营销能力;\n4、1.0%(约3.5百万港元)将用于在天津建设新生产基地;\n5、5.0%(约16.5百万港元)将用作营运资金及其他一般企业用途。","industryId":"204005","industryName":"医疗保健","business":"公司致力于开发及商业化具有可观市场潜力的诊断及治疗放射性药物,根据灼识咨询报告,公司是中国首家(i)获得创新放射性药物上市批准的企业;(ii)以MAH身份获得创新放射性药物生产许可的企业;及(iii)完成治疗用放射性配体注册临床试验并获国家药监局受理NDA的企业。","subscribed":32.83,"marketCap":3411999999.9999995,"minimumCapital":3434.29,"overAllotment":true,"lotSize":50,"issueOpenRate":0.1,"subscribeGear":"50,100,150,200,250,300,350,400,450,500,600,700,800,900,1000,1500,2000,2500,3000,3500,4000,4500,5000,6000,7000,8000,9000,10000,20000,30000,40000,50000,60000,70000,80000,90000,100000,125000,150000,175000,200000,225000,250000,275000,300000,328050","issueRatio":0.1,"offeringMechanism":"B"},"greyMarketDetail":{"greyDate":"2026-11-23","greyDateTimestamp":1795363200000,"greyOpeningTime":1795421700000,"greyClosingTime":1795429800000,"showGreyQuote":false,"openProspectusDate":"2026-11-16","listingDate":"2026-11-24"},"lotSize":50,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09941/tweets","defaultTab":"tweets","newsList":[{"id":"2683661015","title":"先通医药开启招股:拟募资4.5亿港元 11月24日上市 上半年亏5亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2683661015","media":"雷递网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683661015?lang=zh_cn&edition=full","pubTime":"2026-11-16 10:49","pubTimestamp":1794797383,"startTime":"0","endTime":"0","summary":"北京先通国际医药科技股份有限公司(简称:“先通医药”,股票代码:“09941”)日前开启招股,准备2026年11月24日在港交所上市。","market":"hk","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20261116/6393042292705744795311108.jpeg","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20261116/6393042292705744795311108.jpeg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.leinews.com/n35735/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["IPOS","09941"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193579181","title":"新股招股 | 先通医药-B今起招股,一手入场费3434.29港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1193579181","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1193579181?lang=zh_cn&edition=full","pubTime":"2026-11-16 09:25","pubTimestamp":1794792315,"startTime":"0","endTime":"0","summary":"XTR003是目前全球首款且唯一一款18F标记的用于心肌脂肪酸代谢的显像剂,用于检测心肌活力。截至最后实际可行日期,该等产品分别受到12项、13项、15项及1项已授权专利保护。假设超额配股权未获行使及发售价为每股股份60.0港元,公司估计将收取的全球发售所得款项净额约为3.291亿港元。","market":"hk","thumbnail":"https://static.tigerbbs.com/e2bc484766922e67d87fdb952e5532ab","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/e2bc484766922e67d87fdb952e5532ab"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09941"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683665899","title":"“核药第一股”先通医药今起招股,预计11月24日挂牌上市,茅台、国资为股东","url":"https://stock-news.laohu8.com/highlight/detail?id=2683665899","media":"独角兽早知道","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683665899?lang=zh_cn&edition=full","pubTime":"2026-11-16 08:11","pubTimestamp":1794787860,"startTime":"0","endTime":"0","summary":"先通医药此次以18A章规则上市,若顺利挂牌,将成为港股“核药第一股”。先通医药当前最具估值弹性的变量,是核心产品XTR008。先通医药的股东名单,在18A公司中属于配置较高、且带有鲜明“产业+国资”色彩的一档。从2005年成立、2016年新三板挂牌、2018年摘牌聚焦核药,到2026年以“核药第一股”的身份启动港股招股,先通医药用二十一年时间在放射性药物这个高壁垒、长周期的赛道里,搭建了一条从回旋加速器到268家医院销售网络的端到端链条。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzU3MTY1MzExOQ==&mid=2247615696&idx=1&sn=d59f53c19f4281ee0d98440d10b9460e&chksm=fd8969a93b3c36ce4ef607cb6b888adf67aec79dc310f87b1cdb0bf1b5e826c94507619e8de1&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09941","BK1161","IPOS","BK1574","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683668134","title":"先通医药-B(09941)11月16日至11月19日招股 拟全球发售656.1万股H股","url":"https://stock-news.laohu8.com/highlight/detail?id=2683668134","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683668134?lang=zh_cn&edition=full","pubTime":"2026-11-16 06:55","pubTimestamp":1794783335,"startTime":"0","endTime":"0","summary":"智通财经APP讯,先通医药-B 于2026年11月16日至11月19日招股,该公司拟全球发售656.1万股H股,其中香港发售占10%,国际发售占90%,发售价将为每股发售股份52.0港元至68.0港元,每手50股,预期股份将于2026年11月24日在联交所开始买卖。截至2024年及2025年12月31日止年度以及截至2025年及2026年6月30日止六个月,公司分别录得收入人民币4410万元、人民币9920万元、人民币3690万元及人民币6130万元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1523361.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IPOS","BK1161","BK1574","BK1515","159938","09941"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168764619","title":"北京先通国际医药科技全球发售启动,最高募资约3.291亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1168764619","media":"公告速递","labels":["SGX"],"top":1,"itemType":null,"share":"https://www.laohunote.com/m/news/1168764619?lang=zh_cn&edition=full","pubTime":"2026-11-16 06:47","pubTimestamp":1794782846,"startTime":"0","endTime":"0","summary":"北京先通国际医药科技股份有限公司的主营业务集中于放射性药物的研发、生产及商业化,拥有13项产品管线,涵盖两款核心产品及多款重点候选产品,主要应用领域包括肿瘤学、神经退行性疾病及心血管领域。公司亦提供CRO/CDMO及营销推广等服务,收入主要来源于货品销售、许可收入、技术服务和营销服务。本次发行前,公司单一最大股东团体持股占公司已发行股本的约27.03%。倘以每股6.0港元计算且超额配股权未行使,预计可募集资金净额约3.291亿港元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"北京先通国际医药科技全球发售启动,最高募资约3.291亿港元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09941"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111380719","title":"北京先通顺际医药科技启动全球发售:拟发行6,561,000股H股并设15%超额配股权","url":"https://stock-news.laohu8.com/highlight/detail?id=1111380719","media":"公告速递","labels":["SGX"],"top":1,"itemType":null,"share":"https://www.laohunote.com/m/news/1111380719?lang=zh_cn&edition=full","pubTime":"2026-11-16 06:46","pubTimestamp":1794782764,"startTime":"0","endTime":"0","summary":"北京先通顺际医药科技股份有限公司成立于2005年,主要从事放射性药物及相关创新放射性配体疗法的研发、商业化及产业化布局,核心面向肿瘤、心血管及神经退行性疾病等领域。本次全球发售完成后,公司未上市股份将转换为H股,并在香港联合交易所主板上市。承销商另获最高不超过初步发售股份总数15%的超额配股权,用于应对市场需求及可能的超额认购。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"北京先通顺际医药科技启动全球发售:拟发行6,561,000股H股并设15%超额配股权","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09941"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177843325","title":"北京先通国际医药科技股份有限公司启动全球发售,计划11月24日登陆港交所","url":"https://stock-news.laohu8.com/highlight/detail?id=1177843325","media":"公告速递","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1177843325?lang=zh_cn&edition=full","pubTime":"2026-11-16 06:35","pubTimestamp":1794782134,"startTime":"0","endTime":"0","summary":"北京先通国际医药科技股份有限公司11月16日发布公告,宣布正式启动H股全球发售并向香港联交所主板递表上市。香港公开发售自11月16日09:00开始,认购将在11月19日12:00截止。公司预计不迟于11月20日12:00完成定价,并将于11月23日23:00前在港交所网站及公司官网公布最终发售价、香港公开发售认购水平、国际发售认购情况及配售结果。若全球发售条件成就,H股预计于11月24日09:00在港交所主板挂牌交易,每手买卖单位为50股。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09941"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680201102","title":"先通医药通过上市聆讯:上半年营收6125万 净亏5亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2680201102","media":"雷递网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680201102?lang=zh_cn&edition=full","pubTime":"2026-11-01 20:40","pubTimestamp":1793536833,"startTime":"0","endTime":"0","summary":"北京先通国际医药科技股份有限公司(简称:“先通医药”)日前通过上市聆讯,准备在港交所上市。","market":"hk","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20261101/6392916240177834583174716.jpeg","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20261101/6392916240177834583174716.jpeg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.leinews.com/n35593/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["IPOS","09941","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679144278","title":"新股消息 | 先通医药通过港交所聆讯 为中国首家获得创新放射性药物上市批准的企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2679144278","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679144278?lang=zh_cn&edition=full","pubTime":"2026-10-29 10:36","pubTimestamp":1793241415,"startTime":"0","endTime":"0","summary":"","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1514870.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","159938","BK1515","09941","BK1574","IPOS"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"https://www.sinotau.com/","compareEarnings":[{"period":"1week","weight":-0.0345},{"period":"1month","weight":-0.0278},{"period":"3month","weight":-0.0589},{"period":"6month","weight":-0.0896},{"period":"1year","weight":-0.1269},{"period":"ytd","weight":-0.0778}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"先通医药专注于创新放射性药物的研发及商业化,布局神经、心血管和肿瘤疾病领域,开发用于精准诊断和靶向治疗的放射性药物。公司总部位于北京,在上海设有研发中心,在江苏、广东和四川建设放射性药物生产基地,并在美国设有分支机构。","exchange":"SEHK","name":"先通医药-B","nameEN":"SINOTAUPHARMA-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.54.0","shortVersion":"4.54.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"先通医药-B(09941)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供先通医药-B(09941)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"先通医药-B,09941,先通医药-B股票,先通医药-B股票老虎,先通医药-B股票老虎国际,先通医药-B行情,先通医药-B股票行情,先通医药-B股价,先通医药-B股市,先通医药-B股票价格,先通医药-B股票交易,先通医药-B股票购买,先通医药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"先通医药-B(09941)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供先通医药-B(09941)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}